Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia

被引：0
|
作者：
Karlo Perica
Jessica Flynn
Kevin J. Curran
Isabelle Rivere
Xiuyan Wang
Brigitte Senechal
Elizabeth Halton
Claudia Diamonte
John Pineda
Yvette Bernal
Mithat Gonen
Michel Sadelain
Renier J. Brentjens
Jae H. Park
机构：
[1] Cellular Therapy Center,Department of Medicine
[2] Memorial Sloan Kettering Cancer Center,Department of Epidemiology & Biostatistics
来源：
Leukemia | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3268 / 3271
页数：3
相关论文
共 50 条
  • [21] THE CHOICE OF CONVENTIONAL CHEMOTHERAPY OR IMMUNOTHERAPY AS BRIDGING THERAPY DOES NOT APPEAR TO IMPACT CLINICAL RESPONSE TO CD19 DIRECTED CAR-T THERAPY IN PEDIATRIC B-ALL
    Rubinstein, Jeremy
    Krupski, Christa
    Dandoy, Christopher
    Khoury, Ruby
    Davies, Stella
    Phillips, Christine
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [22] CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study
    Jiahua Niu
    Huiying Qiu
    Fang Xiang
    Lin Zhu
    Jun Yang
    Chongmei Huang
    Kun Zhou
    Yin Tong
    Yu Cai
    Baoxia Dong
    Yuan Lu
    Xuedong Sun
    Liping Wan
    Xueying Ding
    Haopeng Wang
    Xianmin Song
    Blood Cancer Journal, 13
  • [23] CD19 REDIRECTED CAR NK CELLS ARE EQUALLY EFFECTIVE BUT LESS TOXIC THAN CAR T CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA
    Caruso, S.
    Quintarelli, C.
    Sivori, S.
    Carlomagno, S.
    Falco, M.
    Boffa, I.
    Orlando, D.
    Guercio, M.
    Abbaszadeh, Z.
    Sinibaldi, M.
    Di Cecca, S.
    Camera, A.
    Cembrola, B.
    Bovetti, K.
    Pitisci, A.
    Andreani, M.
    Vinti, L.
    Del Bufalo, F.
    Algeri, M.
    Pira, G. Li
    Moseley, A.
    De Angelis, B.
    Moretta, L.
    Locatelli, F.
    HAEMATOLOGICA, 2019, 104 : 4 - 4
  • [24] A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia
    Masih, Katherine E.
    Gardner, Rebecca A.
    Chou, Hsien-Chao
    Abdelmaksoud, Abdalla
    Song, Young K.
    Mariani, Luca
    Gangalapudi, Vineela
    Gryder, Berkley E.
    Wilson, Ashley L.
    Adebola, Serifat O.
    Stanton, Benjamin Z.
    Wang, Chaoyu
    Milewski, David
    Kim, Yong Yean
    Tian, Meijie
    Cheuk, Adam Tai -Chi
    Wen, Xinyu
    Zhang, Yue
    Altan-Bonnet, Gregoire
    Kelly, Michael C.
    Wei, Jun S.
    Bulyk, Martha L.
    Jensen, Michael C.
    Orentas, Rimas J.
    Khan, Javed
    BLOOD ADVANCES, 2023, 7 (15) : 4218 - 4232
  • [25] Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia
    Xian Zhang
    Junfang Yang
    Jingjing Li
    Wenqian Li
    Dan Song
    Xin-an Lu
    Fei Wu
    Jianqiang Li
    Dandan Chen
    Xiangqun Li
    Zhongwei Xu
    Shuqiang Liu
    Ziyu Li
    Kui Ying
    Peihua Lu
    Cancer Immunology, Immunotherapy, 2022, 71 : 689 - 703
  • [26] Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia
    Zhang, Xian
    Yang, Junfang
    Li, Jingjing
    Li, Wenqian
    Song, Dan
    Lu, Xin-An
    Wu, Fei
    Li, Jianqiang
    Chen, Dandan
    Li, Xiangqun
    Xu, Zhongwei
    Liu, Shuqiang
    Li, Ziyu
    Ying, Kui
    Lu, Peihua
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (03) : 689 - 703
  • [27] Multi-omic analysis identifies mechanisms of resistance to CD19 CAR T-cell therapy in children with acute lymphoblastic leukemia
    Masih, Katherine E.
    Gardner, Rebecca
    Chou, Hsien-Chao
    Abdelmaksoud, Abdalla
    Song, Young K.
    Mariani, Luca
    Gangalapudi, Vineela
    Gryder, Berkley E.
    Wilson, Ashley
    Adebola, Serifat O.
    Stanton, Benjamin Z.
    Wang, Chaoyu
    Wen, Xinyu
    Altan-Bonnet, Gregoire
    Kelly, Michael C.
    Wei, Jun S.
    Bulyk, Martha L.
    Jensen, Michael C.
    Orentas, Rimas J.
    Khan, Javed
    CANCER RESEARCH, 2022, 82 (12)
  • [28] Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia
    Dekker, Linde
    Calkoen, Friso G.
    Jiang, Yilin
    Blok, Hilly
    Veldkamp, Saskia R.
    De Koning, Coco
    Spoon, Maike
    Admiraal, Rick
    Hoogerbrugge, Peter
    Vormoor, Britta
    Vormoor, H. Josef
    Visscher, Henk
    Bierings, Marc
    Van der Vlugt, Marieke
    Van Tinteren, Harm
    Nijstad, A. Laura
    Huitema, Alwin D. R.
    Van der Elst, Kim C. M.
    Pieters, Rob
    Lindemans, Caroline A.
    Nierkens, Stefan
    BLOOD ADVANCES, 2022, 6 (07) : 1969 - 1976
  • [29] Impact of Bridging Chemotherapy on Clinical Outcomes of CD19 CAR T Therapy in Relapse/Refractory Diffuse Large B- Cell Lymphoma in Real World Experience
    Paillassa, Jerome
    Vercellino, Laetitia
    Di Blasi, Roberta
    Bernard, Sophie
    Moatti, Hannah
    Bommier, Come
    Guerra, Matteo
    Meignin, Veronique
    Chevret, Sylvie
    Thieblemont, Catherine
    BLOOD, 2019, 134
  • [30] Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy
    Kong, Delin
    Yang, Tingting
    Geng, Jia
    Jing, Ruirui
    Zhang, Qiqi
    Wei, Guoqing
    Huang, He
    Hu, Yongxian
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2022, 23 (10): : 876 - 880
12345